Skip to content

Efficacy evaluation of acupuncture on autism spectrum disorder and research on the effects of excitatory/inhibitory neurotransmitters

Efficacy evaluation of acupuncture on autism spectrum disorder and research on the effects of excitatory/inhibitory neurotransmitters based on

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064729
Enrollment
Unknown
Registered
2022-10-15
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Acupuncture 1 set:Acupuncture on the head and heart meridian points
Acupuncture 2 set:Acupuncture on the head points

Sponsors

The First Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children who meet the diagnostic criteria for ASD in DSM-5; 2. Children aged 2-6 years old; 3. Children who have not participated in other clinical observations and other intervention methods in the past 30 days; 4. The guardian of the child is aware of the intervention and the child cooperates well, and can persist in completing the entire treatment cycle; 5. The children's guardians agreed to join the study voluntarily and signed the "informed consent form".

Exclusion criteria

Exclusion criteria: 1. Children who not meet the diagnostic criteria and inclusion criteria; 2. Rett syndrome, childhood disintegrating mental disorder (Heller syndrome), expressive or receptive language disorder, childhood schizophrenia, mental retardation and other children with mental illnesses in children; 3. Children with severe hearing impairment and visual impairment; 4. Children with severe heart, lung, kidney and other important organ diseases.

Design outcomes

Primary

MeasureTime frame
Childhood Autism Rating Scale(CARS);Psychoeducational Profile (Third Edition);GesellDevelopmentalScales;Glutamate;gamma-aminobutyric acid;

Countries

China

Contacts

Public ContactYun Xia

The First Hospital of Hunan University of Chinese Medicine

421626125@qq.com+86 15111160823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026